86 research outputs found

    Hs 76 : Cicero: De officiis, dt. - Goldene Bulle - Freiheiten - Johannes Hartlieb: Kunst der gedächtnüs (um 1475)

    Get PDF
    Fair allocation of flows in multicommodity networks has been attracting a growing attention. In Max-Min Fair (MMF) flow allocation, not only the flow of the commodity with the smallest allocation is maximized but also, in turn, the second smallest, the third smallest, and so on. Since the MMF paradigm allows to approximate the TCP flow allocation when the routing paths are given and the flows are elastic, we address the network routing problem where, given a graph with arc capacities and a set of origin-destination pairs with unknown demands, we must route each commodity over a single path so as to maximize the throughput, subject to the constraint that the flows are allocated according to the MMF principle. After discussing two properties of the problem, we describe a column generation based heuristic and report some computational results

    Changes in hemostasis parameters in nonfatal methicillin-sensitive Staphylococcus aureus bacteremia complicated by endocarditis or thromboembolic events : a prospective gender-age adjusted cohort study

    Get PDF
    The aim of this study was to examine the changes in hemostasis parameters in endocarditis and thromboembolic events in nonfatal methicillin-sensitive Staphylococcus aureus bacteremia (MS-SAB) - a topic not evaluated previously. In total, 155 patients were recruited and were categorized according to the presence of endocarditis or thromboembolic events with gender-age adjusted controls. Patients who deceased within 90 days or patients not chosen as controls were excluded. SAB management was supervised by an infectious disease specialist. Patients with endocarditis (N = 21), compared to controls (N = 21), presented lower antithrombin III at day 4 (p <0.05), elevated antithrombin III at day 90 (p <0.01), prolonged activated partial thromboplastin time at days 4 and 10 (p <0.05), and enhanced thrombin-antithrombin complex at day 4 (p <0.01). Thromboembolic events (N = 8), compared to controls (N = 34), significantly increased thrombin-antithrombin complex at day 4 (p <0.05). In receiver operating characteristic analysis, the changes in these hemostasis parameters at day 4 predicted endocarditis and thromboembolic events (p <0.05). No differences in hemoglobin, thrombocyte, prothrombin fragment, thrombin time, factor VIII, D-dimer or fibrinogen levels were observed between cases and controls. The results suggest that nonfatal MS-SAB patients present marginal hemostasis parameter changes that, however, may have predictability for endocarditis or thromboembolic events. Larger studies are needed to further assess the connection of hemostasis to complications in SAB.Peer reviewe

    Treatment options for wastewater effluents from pharmaceutical companies

    Full text link

    Bin weather data for five climatic zones of Morocco

    No full text

    Immunohistochemical evaluation of bcl-2, ER-alpha, caspase -3, -8, -9, PCNA and Ki-67 expressions in canine mammary carcinomas

    No full text
    PubMedID: 29565181We investigated the expression of bcl-2, estrogen receptor alpha (ER-alpha), caspase-3, -8, -9, proliferating cell nuclear antigen (PCNA) and Ki-67 in canine mammary carcinomas. We used 65 paraffin embedded and re-diagnosed archival canine mammary tumor samples to which we applied the routine streptavidin-biotin-peroxidase technique. Seventeen cases were re-diagnosed as tubulopapillary carcinoma, 31 were re-diagnosed as complex carcinoma and 17 were re-diagnosed as carcinosarcoma. Differences of expression of bcl-2 and PCNA were statistically significant according to tumor type. Differences in expression of ER-alpha, caspase-3, -8, -9 and Ki-67 were not statistically significant. Differences of expression of bcl-2 and PCNA were statistically significant compared to ER-alpha, caspase-3, -8, -9 and Ki-67 in carcinosarcomas. We report the prognostic significance of bcl-2 and PCNA expression in canine mammary carcinosarcomas. © 2018, © 2018 The Biological Stain Commission.0193-NAP-13Our study was supported by Scientific Projects Commission of University of Mehmet Akif Ersoy (Project no. 0193-NAP-13)
    corecore